Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) reported EBT Margin of 3605.3% for Q3 2024, up 1972153.0% on a YoY basis from N/an in Q4 2023, and up 72.21% sequentially from 12975.2% in Q2 2024.
Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of EBT Margin data on file, last reported at 3605.3% in Q3 2024.
- For the quarter ending Q3 2024, EBT Margin rose 1972153.0% year-over-year to 3605.3%; the trailing twelve-month figure through Dec 2025 stood at 23082.58% (changed N/A YoY), and the FY2024 full-year result was 23481.41%, down 346841.0% from the prior year.
- EBT Margin advanced to 3605.3% in Q3 2024, from 12975.2% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 3605.3% in Q3 2024 to a low of 36800.0% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Adagio Medical Holdings | 21.49 Mn | 21.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,605.30% |
| Jun 30, 2024 | -12,975.20% |
| Mar 31, 2024 | -36,800.00% |
| Dec 31, 2023 | -8,765.38% |
| Sep 30, 2023 | -23,326.83% |